Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls

Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact o...

Full description

Bibliographic Details
Main Authors: Paulo Gustavo Kotze, Subrata Ghosh, Willem A. Bemelman, Remo Panaccione
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2017-04-01
Series:Intestinal Research
Subjects:
Online Access:https://doi.org/10.5217/ir.2017.15.2.160